Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Update

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,460,000 shares, a decline of 16.6% from the February 28th total of 1,750,000 shares. Currently, 4.1% of the shares of the company are sold short. Based on […]

Related Keywords

Hong Kong ,Williamj Peters , ,Anfield Capital Management ,Amphastar Pharmaceuticals Price Performance ,Amphastar Pharmaceuticals Inc ,Amphastar Pharmaceuticals Company Profile ,Us Bancorp ,Hong Kong Ltd ,Dupont Capital Management Corp ,Amphastar Pharmaceuticals ,News Ratings For Amphastar Pharmaceuticals Daily ,Institutional Trading Of Amphastar Pharmaceuticals ,Insider Activity At Amphastar Pharmaceuticals ,Securities Exchange Commission ,Nasdaq ,Get Rating ,Exchange Commission ,Capital Management ,Kong Ltd ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredients Products ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Stocks ,Options ,Put ,Call ,